These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26026393)
21. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer. Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678 [TBL] [Abstract][Full Text] [Related]
22. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis. Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592 [TBL] [Abstract][Full Text] [Related]
23. Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer. Je Y; Lee JE; Ma J; Zhang X; Cho E; Rosner B; Selhub J; Fuchs CS; Meyerhardt J; Giovannucci E Cancer Causes Control; 2013 Apr; 24(4):719-29. PubMed ID: 23340905 [TBL] [Abstract][Full Text] [Related]
24. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Chan AT; Ogino S; Giovannucci EL; Fuchs CS Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010 [TBL] [Abstract][Full Text] [Related]
26. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020 [TBL] [Abstract][Full Text] [Related]
27. Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease. De Haan JJ; Haitjema S; den Ruijter HM; Pasterkamp G; de Borst GJ; Teraa M; Verhaar MC; Gremmels H; de Jager SCA J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855167 [TBL] [Abstract][Full Text] [Related]
28. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study. Liu B; Zhao Y; Guo L Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589 [TBL] [Abstract][Full Text] [Related]
29. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
30. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy. Jobin G; Rodriguez-Suarez R; Betito K Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834 [TBL] [Abstract][Full Text] [Related]
31. A prospective study of plasma C-peptide and colorectal cancer risk in men. Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117 [TBL] [Abstract][Full Text] [Related]
32. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934 [TBL] [Abstract][Full Text] [Related]
33. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer. Wu HK; Liu C; Fan XX; Wang H; Zhou L Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451 [TBL] [Abstract][Full Text] [Related]
34. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy. Venè R; Costa D; Augugliaro R; Carlone S; Scabini S; Casoni Pattacini G; Boggio M; Zupo S; Grillo F; Mastracci L; Pitto F; Minghelli S; Ferrari N; Tosetti F; Romairone E; Mingari MC; Poggi A; Benelli R Cells; 2020 Mar; 9(3):. PubMed ID: 32168749 [TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases. Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ; Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372 [TBL] [Abstract][Full Text] [Related]
37. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
38. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer]. Wu F; Chen L; Wu W; Jiang B; Su X Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527 [TBL] [Abstract][Full Text] [Related]
39. Association between molecular subtypes of colorectal cancer and patient survival. Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443 [TBL] [Abstract][Full Text] [Related]
40. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study. Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]